Search Within

Noushin Rahnamay Farnoud

Formats
  1. Journal Article (26)
  2. Meeting Abstract (22)
  3. Research Letter (3)
Groups
  1. Center for Hematologic Malignancies (45)
  2. Department of Medicine (41)
  3. Hematologic Malignancies, Division of (39)
  4. Adult Leukemia (38)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (29)
  6. Executive Committee, Center for Hematologic Malignancies (29)

More Groups

People
  1. Raajit Rampal (24)
  2. Elli Papaemmanuil (21)
  3. Ross Levine (21)
  4. Erin McGovern (16)
  5. Juan Arango Ossa (16)
  6. Juan Medina (15)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (5)
  4. 2022 (6)
  5. 2021 (4)
  6. 2020 (7)

More Years

Publications
  1. Blood (24)
  2. Blood Advances (5)
  3. Clinical Cancer Research (3)
  4. Cancer Cell (2)
  5. Cancer Discovery (2)
  6. Leukemia (2)

More Publications

Publishers
  1. American Society of Hematology (29)
  2. American Association for Cancer Research (6)
  3. Nature Publishing Group (4)
  4. Cell Press (2)
  5. Amer Soc Clinical Investigation Inc (1)
  6. American Society for Clinical Investigation (1)

More Publishers

Results (51)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • De Novo myelodysplastic syndromes in patients 20–50 years old are enriched for adverse risk features
    Journal Article

    Epstein-Peterson, Z. D.; Spitzer, B.; Derkach, A.; Arango, J. E.; McCarter, J. G. W.; Medina-Martínez, J. S.; McGovern, E.; Farnoud, N. R.; Levine, R. L.; Tallman, M. S.
    Leukemia Research (2022)

    Fulltext@MSK | Save
  • Characterization of disease-propagating stem cells responsible for myeloproliferative neoplasm–blast phase
    Journal Article

    Wang, X.; Rampal, R. K.; Hu, C. S.; Tripodi, J.; Farnoud, N.; Petersen, B.; Rossi, M. R.; Patel, M.; McGovern, E.; Najfeld, V.; more...
    JCI Insight (2022)

    Fulltext@MSK | Save
  • Bone marrow surveillance of pediatric cancer survivors identifies clones that predict therapy-related leukemia
    Journal Article

    Spitzer, B.; Rutherford, K. D.; Gundem, G.; McGovern, E. M.; Millard, N. E.; Arango Ossa, J. E.; Cheung, I. Y.; Gao, T.; Levine, M. F.; Zhang, Y.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Treatment of myelofibrosis patients with the TGF-β 1/3 inhibitor AVID200 (MPN-RC 118) induces a profound effect on platelet production
    Meeting Abstract

    Mascarenhas, J.; Kosiorek, H. E.; Bhave, R.; Palmer, J. M.; Kuykendall, A. T.; Mesa, R. A.; Rampal, R.; Gerds, A. T.; Yacoub, A.; Pettit, K. M.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Genomic and evolutionary portraits of disease relapse in acute myeloid leukemia
    Research Letter

    Rapaport, F.; Neelamraju, Y.; Baslan, T.; Hassane, D.; Gruszczynska, A.; Robert de Massy, M.; Farnoud, N.; Haddox, S.; Lee, T.; Medina-Martinez, J.; more...
    Leukemia (2021)

    Fulltext@MSK | Save
  • LKB1/STK11 is a tumor suppressor in the progression of myeloproliferative neoplasms
    Journal Article

    Marinaccio, C.; Suraneni, P.; Celik, H.; Volk, A.; Wen, Q. J.; Ling, T.; Bulic, M.; Lasho, T.; Koche, R. P.; Famulare, C. A.; more...
    Cancer Discovery (2021)

    Fulltext@MSK | Save
  • Flow cytometric immunophenotypic alterations of persistent clonal haematopoiesis in remission bone marrows of patients with NPM1-mutated acute myeloid leukaemia
    Journal Article

    Loghavi, S.; DiNardo, C. D.; Furudate, K.; Takahashi, K.; Tanaka, T.; Short, N. J.; Kadia, T.; Konopleva, M.; Kanagal-Shamanna, R.; Farnoud, N. R.; more...
    British Journal of Haematology (2021)

    Fulltext@MSK | Save
  • Molecular predictors and effectiveness of measurable residual disease (MRD) eradication with chemotherapy and allogeneic stem cell transplantation for acute myeloid leukemia
    Meeting Abstract

    Stahl, M.; Derkach, A.; Famulare, C.; Cho, C.; Devlin, S.; Farnoud, N.; Menghrajani, K.; Patel, M. A.; Cai, S. F.; Geyer, M. B.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Clonal hematopoiesis and its implications for flow cytometric assessment of measurable residual disease in patients with NPM1-mutated acute myeloid leukemia
    Meeting Abstract

    Loghavi, S.; DiNardo, C. D.; Takahashi, K.; Kanagal-Shamanna, R.; Tanaka, T.; Furudate, K.; Short, N. J.; Kadia, T. M.; Konopleva, M.; Farnoud, N.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Atypical presentation of erythroid/megakaryocytic leukemic transformation of a myeloproliferative neoplasm associated with mutation and loss of TP53
    Journal Article

    Chernak, B. J.; Sen, F.; Farnoud, N.; Bou Ayache, J.; Zhang, Y.; DeWolf, S.; Rampal, R. K.
    HemaSphere (2020)

    Fulltext@MSK | Save